Codis
St. Louis, Missouri, United States · Biotechnology, Manufacturing, Pharmaceutical
Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. The company combines decades of regulatory expertise and manufacturing strength under one brand. With extensive manufacturing space and multiple GMP facilities, Codis is positioned
Key facts
- Headquarters
- St. Louis, Missouri, United States
- Employees
- Unknown
- Industries
- Biotechnology, Manufacturing, Pharmaceutical
- Status
- Private
- Website
- codis.com
- Company page
Recent activity at Codis
- : Codis Appoints Steve Facer as Chief Commercial Officer
- : Codis secures growth capital from 1315 Capital to expand its commercial manufacturing capacity in Haverhill, with support from BroadOak Capital Partners and RCT.
- : Codis has launched as a new global CDMO specializing in commercial-scale spray drying and amorphous solid dispersions.
Codis funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Funding Round | Undisclosed |
Leadership
- Brian, Director of Manufacturing Operations
- Steve Facer, Chief Commercial Officer
- Niranjan, CDMO and CMO Veteran
- Mike Kanan, Chief Financial Officer
- Nicolas Fortin, Chief Executive Officer
Verified email and direct lines for Codis’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Codis in the news
- Codis Completes Acquisition of Catalent's Nottingham, UK Facility, Expanding Europe's Premier Spray Dry Network - PR Newswire (Aug 03, 2026)
- Codis To Acquire Catalent's Nottingham, UK Facility to Create Europe's Leading End-to-End Spray Dry Capability - PR Newswire (Jul 06, 2026)
- Codis Unlocks Commercial-Scale Amorphous Solid Dispersions Manufacturing with GEA PSD4 Solvent Spray Dryer Investment - PR Newswire (Mar 04, 2026)
- The US Is Storing Migrant Children’s DNA in a Criminal Database - WIRED (May 29, 2025)
- Washington Lawfully Owed DNA Project has Added Over 2,000 to CODIS - Forensic Magazine (Aug 14, 2023)
Companies similar to Codis
- Dexcel Pharma USA · Biotechnology, Manufacturing, Pharmaceutical
- Helus Pharma · Biotechnology, Manufacturing, Pharmaceutical
- Tirupati Group · Biotechnology, Manufacturing, Pharmaceutical
- Magle Chemoswed Holding AB · Biotechnology, Manufacturing, Pharmaceutical
- Piramal Pharma Solutions · Biotechnology, Manufacturing, Pharmaceutical
About Codis: questions and answers
What does Codis do?
Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. The company combines decades of regulatory expertise and manufacturing strength under one brand. With extensive manufacturing space and multiple GMP facilities, Codis is positioned
Where is Codis headquartered?
Codis is headquartered in St. Louis, Missouri, United States.
Has Codis raised funding?
Yes. Fundz has recorded 1 funding event for Codis. The most recent, Funding Round of Undisclosed, was in Oct 2025.
Who leads Codis?
Nicolas Fortin is a Chief Executive Officer at Codis.
What is the latest news on Codis?
On Sep 24, 2026, Codis Appoints Steve Facer as Chief Commercial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy